Nombre del producto:Riboflavin phosphate sodium

IUPAC Name:sodium (2R,3R,4S)-1-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-3,4-dihydroxy-5-(phosphonooxy)pentan-2-olate

CAS:130-40-5
Fórmula molecular:C17H20N4NaO9P
Pureza:98%
Número de catálogo:CM182529
Peso molecular:478.33

Unidad de embalaje Stock disponible Precio($) Cantidad
CM182529-25g 3-4 Weeks ijijƚ
CM182529-100g 3-4 Weeks ħǸħ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :130-40-5
Fórmula molecular:C17H20N4NaO9P
Punto de fusión:-
Código de sonrisas:CC1=CC2=C(C=C1C)N=C(C(N2C[C@H]([C@H]([C@H](COP(O)(O)=O)O)O)[O-])=N3)C(NC3=O)=O.[Na+]
Densidad:
Número de catálogo:CM182529
Peso molecular:478.33
Punto de ebullición:
Nº Mdl:MFCD00065362
Almacenamiento:Store at room temperature.

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Related Products